rivastigmine has been researched along with chalcone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, P; Ban, Y; Hu, J; Mi, J; Sang, Z; Tan, Z; Tang, L; Wang, C; Wang, J; Wang, K; Wu, A; Xu, R; Zhang, J; Zhu, G | 1 |
1 other study(ies) available for rivastigmine and chalcone
| Article | Year |
|---|---|
Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Chalcone; Chalcones; Chalones; Cholinesterase Inhibitors; Donepezil; Drug Design; Neuroprotective Agents; Positron Emission Tomography Computed Tomography; Rats; Rivastigmine; Structure-Activity Relationship | 2022 |